Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 5.15% | 58.40 | 0.0% | $1738.44m | |
| GILD | Gilead Sciences, Inc. | -0.49% | 74.95 | 1.0% | $1311.94m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.54% | 581.35 | 2.5% | $966.57m | |
| AMGN | Amgen, Inc. | -0.34% | 223.37 | 1.3% | $644.14m | |
| NVAX | Novavax, Inc. | 0.36% | 45.00 | 102.0% | $581.79m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.15% | 277.80 | 1.9% | $545.53m | |
| BIIB | Biogen, Inc. | -0.26% | 299.73 | 1.6% | $409.34m | |
| ILMN | Illumina, Inc. | -1.92% | 365.84 | 3.5% | $381.70m | |
| SRNE | Sorrento Therapeutics, Inc. | -0.07% | 4.95 | 1.8% | $297.70m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.98% | 115.54 | 2.0% | $267.65m | |
| SGEN | Seattle Genetics, Inc. | -0.16% | 151.31 | 6.1% | $254.10m | |
| A | Agilent Technologies, Inc. | 0.58% | 87.19 | 1.6% | $200.66m | |
| BMRN | BioMarin Pharmaceutical, Inc. | -1.40% | 104.12 | 4.3% | $177.26m | |
| CODX | Co-Diagnostics, Inc. | -1.00% | 17.30 | 0.0% | $169.20m | |
| INCY | Incyte Corp. | -0.36% | 100.19 | 2.5% | $156.93m |
Company Profile
Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializes of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.